|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.895 EUR | -0.26% |
|
-2.07% | +33.02% |
| 06-29 | Sopharma AD Approves Gross Dividend for 2025 | CI |
| 06-22 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended May 2026 | CI |
| Market Cap | 1.9B 1.14B 1B 927M 853M 1.61B 109B 1.65B 11.05B 4.34B 53.66B 4.29B 4.19B 185B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44B 1.47B 1.29B 1.19B 1.1B 2.07B 140B 2.11B 14.2B 5.57B 68.94B 5.51B 5.39B 238B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | - |
| 1 day | -0.26% | ||
| 1 week | -2.07% | ||
| Current month | -1.81% | ||
| 1 month | +0.26% | ||
| 3 months | +8.29% | ||
| 6 months | -2.07% | ||
| Current year | +33.02% |
| 1 week | 1.85 |  | 1.94 |
| 1 month | 1.85 | | 1.94 |
| Current year | 1.41 | | 2 |
| 1 year | 1.21 | | 2 |
| 3 years | 0.89 | | 2 |
| 5 years | 0.58 | | 2 |
| 10 years | 0.41 | | 2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/09/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.26% | -2.07% | +42.81% | +111.42% | 1.14B | |
| +0.71% | +2.04% | -15.52% | -32.74% | 14.96B | |
| -1.49% | +1.23% | -25.68% | -36.42% | 6.91B | |
| +0.62% | -2.21% | -20.67% | -4.88% | 5.9B | |
| +2.93% | +3.09% | -15.37% | -33.74% | 3.7B | |
| -2.55% | -6.33% | -38.48% | -15.48% | 3.13B | |
| -0.76% | -2.92% | -29.80% | -48.19% | 3.19B | |
| +2.44% | +5.12% | +6.48% | -34.42% | 3.04B | |
| -1.64% | -2.63% | +97.50% | - | 2.55B | |
| +0.51% | -2.17% | -21.05% | -3.23% | 2.46B | |
| Average | +0.05% | -1.50% | -1.98% | -10.85% | 4.7B | |
| Weighted average by Cap. | +0.18% | -1.59% | -11.46% | -24.36% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.13B 1.04B 960M 1.82B 123B 1.85B 12.44B 4.88B 60.4B 4.83B 4.72B 209B | 2.63B 1.58B 1.39B 1.28B 1.18B 2.24B 151B 2.28B 15.31B 6B 74.32B 5.94B 5.81B 257B |
| Net income | 77.85M 46.75M 41.01M 37.98M 34.95M 66.1M 4.47B 67.39M 453M 178M 2.2B 176M 172M 7.59B | 134M 80.19M 70.34M 65.15M 59.94M 113M 7.68B 116M 776M 305M 3.77B 301M 295M 13.02B |
| Net Debt | 444M 267M 234M 217M 199M 377M 25.53B 385M 2.58B 1.01B 12.54B 1B 980M 43.3B | 541M 325M 285M 264M 243M 460M 31.11B 469M 3.15B 1.23B 15.28B 1.22B 1.19B 52.77B |
Employees
6,005
Sector
Drug Retailers
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | €1.895 | -0.26% | 5,009 |
| 10/07/26 | €1.900 | 0.00% | 439 |
| 09/07/26 | €1.900 | -1.55% | 2,430 |
| 08/07/26 | €1.930 | -0.26% | 6,672 |
| 07/07/26 | €1.935 | 0.00% | 887 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
